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Abstract
Background: Infection by pathogenic viruses results in rapid epithelial damage and significantly impacts on the
condition of the upper respiratory tract, thus the effects of viral infection may induce changes in microbiota. Thus,
we aimed to define the healthy microbiota and the viral pathogen-affected microbiota in the upper respiratory
tract. In addition, any association between the type of viral agent and the resultant microbiota profile was assessed.
Methods: We analyzed the upper respiratory tract bacterial content of 57 healthy asymptomatic people (17 health-care
workers and 40 community people) and 59 patients acutely infected with influenza, parainfluenza, rhino, respiratory
syncytial, corona, adeno, or metapneumo viruses using culture-independent pyrosequencing.
Results: The healthy subjects harbored primarily Streptococcus, whereas the patients showed an enrichment of
Haemophilus or Moraxella. Quantifying the similarities between bacterial populations by using Fast UniFrac analysis
indicated that bacterial profiles were apparently divisible into 6 oropharyngeal types in the tested subjects. The
oropharyngeal types were not associated with the type of viruses, but were rather linked to the age of the subjects.
Moraxella nonliquefaciens exhibited unprecedentedly high abundance in young subjects aged <6 years. The genome of
M. nonliquefaciens was found to encode various proteins that may play roles in pathogenesis.
Conclusions: This study identified 6 oropharyngeal microbiome types. No virus-specific bacterial profile was discovered,
but comparative analysis of healthy adults and patients identified a bacterium specific to young patients,
M. nonliquefaciens.
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Background
Recent culture-independent community analysis per-
formed on the human microbiome has provided an
overall picture of commensal microbial communities.
Studies have revealed that diverse microbes occupying
body habitats with strong niche specialization both
within and among individuals [1]. In the case of the re-
spiratory tract microbiome, a catalogue was initially
established in 2009 [2] and then respiratory microorgan-
isms were extensively characterized [3-8]. Collectively,
studies to date have revealed that the respiratory tract
harbors a homogenous microbiota that decreases in
biomass from the upper to the lower tract [5], and that
the lung microbiome resembles the oral microbiome,
although these microbiomes are distinguished by the
overrepresentation of distinct bacterial species in the
lung [7]. As with other human-body habitats, the core
microbiome of nasopharynx remains undefined because
it varies substantially from person to person [3]. How-
ever, existence of core microbiome was observed despite
the significant inter-individual variation [8]. One study
reported that the microbial composition of the upper
respiratory tract is typically unique to each person and it
changes little over time [4].
Although the available evidence is not sufficiently
strong, microbiome types are speculated to eventually
affect a person’s risk of disease or response to distinct
drugs [9]. The human microbiota is considered to benefit
the host by promoting the differentiation of the mucosal
structure and function, stimulating both the innate and
adaptive immune systems, and providing “colonization
resistance” against pathogen invasion [10]. Recently, the
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composition of the airway microbiota has been suggested
to play roles in determining the presence and severity of
diseases [11,12]. For example, the clinical outcomes of
respiratory infections caused by Pseudomonas aeruginosa
vary depending on the diversity of the airway microbiota
[13,14], and a temporal loss of the diversity is linked to
the development of ventilator-associated pneumonia and
patient mortality [12,13]. The importance of intact com-
mensal microbiota was also demonstrated in viral infec-
tion, with the commensal microbiota composition critically
regulating host immune response following influenza virus
infection [15]. To reveal the links that exist between
microbiome types and clinical traits, we have to first
understand the diversity of the microbial community in
target body sites.
Most respiratory tract infections are caused by viruses
including rhinovirus, respiratory syncytial virus, para-
influenza virus, adenovirus, coronavirus, human metap-
neumovirus, and influenza virus. Infection by pathogenic
viruses significantly changes the condition of the respira-
tory tract as a result of the epithelial damage caused by
viral invasion itself and/or by inflammatory mediators
produced by the host immune response [16]. Given, the
pathophysiology and mechanism of local immune re-
sponses are virus specific [16], a virus-specific bacterial
profile in the respiratory tract could potentially be char-
acterized. Discovering any specific bacterial species that
exhibits a tendency of opportunistic infection or co-
infection in a viral species-dependent would benefit future
preventive measures and current treatments. To date, no
study has evaluated whether the composition of the re-
spiratory microbiota changes in relation to the type of
infectious virus.
In this study, our aim was to determine whether a viral
infection-related bacterial profile exists in the respiratory
tract and evaluate any disparities in the microbiota
structure that develops depending on the infectious virus
species. We used culture-independent high-throughput
sequencing to analyze the bacterial content in the upper
respiratory tract of patients and healthy asymptomatic
people. We also examined the presence or absence of




This study was approved by the Institutional Review Board
of the Severance Hospital, Yonsei University Health System,
Seoul, Korea (protocols 4-2010-0652, 4-2011-0159, and
4-2011-0862). Patients and healthy adults provided written
informed consent to be enrolled. De-identified demo-
graphic data and clinical measures were taken from elec-
tronic medical record system. Additional file 1: Table S1
presents the list and features of samples used in this study.
Subjects and sample collection
We selected 59 patients with confirmed acute viral in-
fections from Yonsei University Hospital during a 30-
month period (December 2010 to May 2013). The viral
agents of the infections were confirmed using PCR by
Yonsei University Hospital. The viruses included influ-
enza (IF, n = 7), parainfluenza (PI, n = 24), rhino (RH,
n = 8), respiratory syncytial (RS, n = 14), corona (CR,
n = 4), adeno (AD, n = 1), and metapneumo (MP, n = 1)
viruses. The upper respiratory tract samples were col-
lected from patients’ oropharynx by using swabs and
suspended in 1 mL of viral transport medium (VTM;
Becton Dickinson Universal Viral Transport, USA). Spu-
tum or nasopharyngeal aspirate was collected when
available instead of swabs. Sputum samples were diluted
with an equal volume of suspension medium and ho-
mogenized as described [17]. The upper respiratory tract
samples were also obtained from healthy adults includ-
ing 17 health-care workers (9 non-ICU and 8 ICU staff )
and 40 community people. The 17 hospital staffs and 7
community people were recruited over the same period
in Yonsei University Hospital (June 2011) and 33 com-
munity people were additionally recruited in the same
hospital (June 2013). The oropharyngeal swabs were
obtained using aseptic technique, suspended in VTM
and transported to the laboratory for further process-
ing. The samples were stored at −80°C until DNA
extraction.
DNA extraction, PCR, and pyrosequencing
DNA was extracted from 200 μL of samples by using a
commercial microbial DNA isolation kit (Qiagen). The
extracted DNA was amplified using primers targeting
the V1 to V3 regions of the prokaryotic 16S rRNA gene
by using methods described elsewhere [18]. DNA was
sequenced by Chunlab Inc. (Seoul, Korea) by using a
Roche/454 GS Junior system according to the manufac-
turer’s instructions. The processing of pyrosequencing
data of 16S rRNA gene sequences were performed as
described elsewhere [18]. Chimeric sequences were de-
tected using UCHIME [19] and EzTaxon-e database
(http://eztaxon-e.ezbiocloud.net; [20]) was used to taxo-
nomically assign each pyrosequencing read.
Phylogenetic analyses
Phylogenetic analyses of 16S rRNA gene sequences were
performed using the neighbor-joining [21] tree method
implemented in MEGA program [22]. An evolutionary
distance matrix was generated for the neighbor-joining
tree according to the model of Jukes and Cantor [23]
and the resultant tree topologies were evaluated using
bootstrap analyses [24].
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Genome analyses
The draft genome sequence of Moraxella nonliquefaciens
DSM 6327T was determined through paired-end shotgun
sequencing performed by using the MiSeq system (Illu-
mina) with 300× coverage. The sequencing reads were as-
sembled using CLC genomics wb5 (CLCbio). Annotation,
comparative genomic analyses and average nucleotide iden-
tity (ANI) calculation were performed as described [25].
Statistical analyses
Random subsampling was conducted to normalize the
data size to 3,000 reads, because the total number of
reads that remained after pre-processing varied depend-
ing on the samples. All statistical analyses were per-
formed using this subset. The Simpson diversity index
[26] was calculated using the rRNA Database Project’s
pyrosequencing pipeline (http://pyro.cme.msu.edu/). The
overall phylogenetic distance between each pair of com-
munities was estimated using the Fast UniFrac web
interface (http://unifrac.colorado.edu/) [27] and visualized
using principal coordinate analysis (PCoA) implemented
in R program (http://www.r-project.org/). To compare
microbiome structures based on categorical metadata,
samples were pooled into binds (healthy/patient, male/fe-
male, VTM/aspirate/sputum, smoking/non-smoking, ages,
causal viruses, etc.) and statistical significance tests were
performed using R program. The significance of differ-
ences in bacterial profiles according to categorical meta-
data was determined using Hotelling’s t test. Significant
bacterial taxa based on categorical metadata were identi-
fied using q-values after multiple testing correction [28] to
eliminate false discovery rates. The difference in Shannon
diversity index among categorical metadata was evaluated
using Wilcox two-sample t test.
Availability of supporting data
The 454 sequencing data supporting this article are
available in the GenBank repository, SUB435282. The
genome data of M. nonliquefacience is under submission




We sequenced 57 upper respiratory tract samples from
healthy adults including 17 health-care workers (9 non-
ICU and 8 ICU staff ) and 40 community people. The 59
patients with confirmed acute viral infections with
influenza (IF, n = 7), parainfluenza (PI, n = 24), rhino
(RH, n = 8), respiratory syncytial (RS, n = 14), corona
(CR, n = 4), adeno (AD, n = 1), and metapneumo (MP,
n = 1) viruses were also successfully sequenced. The
pyrosequencing of 16S rRNA gene amplicons resulted
in 786,152 quality-filtered reads for the 116 samples.
We observed an average of 823 bacterial phylotypes
(97% clustering) for each samples (range 237 to 1,851).
In the sample-size-normalized (3,000 nt) subsamples,
the number of bacterial species ranged from 180 to
615 (average, 371), depending on samples.
Microbiota of healthy adults
The genus Streptococcus was identified as the core
microbiome of the healthy human respiratory tract. In
all healthy subjects tested in this study, members of
Streptococcus dominated the bacterial community, exhi-
biting an average abundance ratio (percentage of the
taxon in the total bacterial community) of 55.8% (range
13.4%–91.1%, depending on subjects) (Table 1). The
genera Neisseria (8.0%) and Gemella (5.3%) were also
dominant in healthy subjects, but their abundance ratios
were considerably less than that of Streptococcus. The
genera observed in all healthy subjects were Streptococcus,
Prevotella, and Veillonella. The genera Haemophilus,
Gemella, Rothia, and Leptotrichia were detected in most
subjects at abundance ratios of 2.0%–8.0%.
Fast UniFrac analyses for the bacterial profiles in
healthy samples showed that hospital staff and community
people were not discriminated based on their bacterial
composition (Additional file 2: Figure S1), and age, sex,
year and month of sample collection, and smoking status
did not discriminate the bacterial profile (data not shown).
Difference between patient and healthy-adult groups
Analyzing the bacterial communities of healthy-adult
and patient groups revealed clear differences. We used
the Shannon index in which higher values represent
higher diversities; the average values calculated for the
healthy-adult and patient groups were 4.83 ± 0.40 and
3.77 ± 0.61, respectively (Figure 1). This indicated that
healthy adults harbored significantly more complex and
diverse microbiota than did patients (p <0.0001, Wilcox
test).
The microbiota profiles of healthy-adult and patient
groups also differed in the relative composition of the
microbiome, which was highlighted in the graph show-
ing the abundant bacterial genera observed in the tested
samples (Figure 2 and Additional file 3: Figure S2). To
identify the bacterial taxa that were more abundant (in a
statistically significant manner) in the patient group than
in the healthy-adult group, p-values were calculated for
all the taxa detected. The result demonstrated that dis-
tinct bacterial genera were overrepresented in the pa-
tient and healthy-adult groups. Whereas Haemophilus
(p = 0.010) and Moraxella (p = 0.028) were identified as
patient group-specific genera, Streptococcus (p = 0.003),
Neisseria (p = 0.003), Gemella (p = 0.003), Aggregatibacter
(p = 0.008), and Actinobacillus (p = 0.001) were deter-
mined to be bacteria specific to the healthy-adult group.
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Table 1 List of dominant bacterial genera and their average abundance (%) in samples
Healthy adults Patients
non ICU ICU staff Community Total IF PI RH RS CR AD MP Total
(n =9) (n =8) (n =40) (n =57) (n =7) (n =24) (n =8) (n =14) (n =4) (n =1) (n =1) (n =59)
Streptococcus 32.1 ± 19.6 57.4 ± 19.8 60.8 ± 21.4 55.8 43.4 ± 28.3 23.3 ± 34.3 52.5 ± 20.3 35.1 ± 32.2 26.3 ± 32.6 0.6 43.8 32.6
Haemophilus 6.4 ± 4.9 6.1 ± 5.1 6.3 ± 7.9 6.3 11.5 ± 26.4 39.6 ± 43.1 7.2 ± 11.8 22.3 ± 37.2 0.1 ± 0.2 84.7 0.5 25.2
Neisseria 13.6 ± 13.4 8.1 ± 6.8 6.7 ± 9.6 8.0 8.2 ± 12.4 0.5 ± 1.1 2.5 ± 4.6 0.7 ± 2.0 0.1 ± 0.1 0.0 1.6 1.7
Moraxella 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 0.3 ± 0.7 9.4 ± 23.2 9.3 ± 26.3 21.6 ± 35.0 6.6 ± 13.2 14.1 0.0 10.9
Prevotella 8.5 ± 7.4 0.6 ± 0.4 4.0 ± 7.1 4.2 5.6 ± 6.3 1.8 ± 6.1 8.0 ± 9.3 1.3 ± 2.8 0.7 ± 0.8 0.1 9.5 3.0
Veillonella 4.7 ± 3.7 1.2 ± 0.7 2.3 ± 3.3 2.5 8.6 ± 9.1 1.5 ± 4.6 4.2 ± 5.6 2.1 ± 3.6 7.3 ± 12.0 0.1 11.2 3.4
Gemella 5.6 ± 8.6 11.4 ± 9.5 4.0 ± 7.4 5.3 0.3 ± 0.6 0.3 ± 1.2 1.5 ± 2.9 0.1 ± 0.3 0.2 ± 0.4 0.0 0.4 0.4
Klebsiella 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.0 0.0 ± 0.0 6.5 ± 22.1 0.0 ± 0.1 4.2 ± 8.6 0.0 ± 0.0 0.0 0.0 3.7
Granulicatella 1.3 ± 1.2 2.7 ± 2.4 0.8 ± 0.9 1.1 4.6 ± 4.7 0.6 ± 2.1 0.8 ± 1.0 3.9 ± 11.4 0.0 ± 0.1 0.0 5.4 1.9
Rothia 0.1 ± 0.1 1.4 ± 1.5 2.7 ± 3.7 2.1 0.3 ± 0.4 0.2 ± 0.7 3.3 ± 5.4 0.3 ± 0.9 0.0 ± 0.1 0.0 1.1 0.7
Leptotrichia 4.8 ± 9.7 0.3 ± 0.3 1.7 ± 5.5 2.0 0.8 ± 0.8 0.2 ± 0.9 0.1 ± 0.2 0.1 ± 0.3 0.4 ± 0.5 0.0 7.3 0.4
Porphyromonas 1.7 ± 2.2 2.9 ± 5.0 1.4 ± 2.8 1.7 2.8 ± 3.4 0.0 ± 0.1 0.2 ± 0.2 0.1 ± 0.3 0.0 ± 0.0 0.0 0.8 0.4
Staphylococcus 0.1 ± 0.2 0.0 ± 0.0 0.0 ± 0.0 0.0 0.1 ± 0.1 1.0 ± 3.6 2.5 ± 7.0 0.4 ± 1.1 17.1 ± 34.2 0.0 0.0 2.0
Abbreviations: ICE intensive care unit, non ICU healthy hospital staff who do not work in ICU, ICU staff healthy hospital staff who work in ICU, Community healthy community people, IF influenza, PI parainfluenza, RH



















To hierarchically visualize the bacterial profile similar-
ities among the samples, a UPGMA dendrogram was
generated from the Fast UniFrac distance matrix. Based
on bacterial composition, the samples analyzed in this
study were divided into 6 oropharyngeal microbiome types
(Additional file 3: Figure S2), with the clusters being char-
acterized by the dominance of several bacterial genera:
Type 1 (dominated by Streptococcus + Prevotella +Veillo-
nella), Type 2 (Streptococcus +Haemophilus +Neisseria),
Type 3 (Streptococcus), Type 4 (Moraxella), Type 5 (Hae-
mophilus), and Type 6 (Klebsiella). Only 4 samples were
not grouped into any of the 6 types. The healthy adults
and a subset of patients harbored bacterial communities
dominated by Streptococcus, and to a lesser extent by
Haemophilus, Neisseria, Prevotella, Veillonella, and/or
Gemella (Types 1–3 in Figure 3). The remaining patients
carried impaired microbiota dominated by Moraxella
(Type 4 in Figure 3), Haemophilus (Type 5), or Klebsiella
(Type 6), and this was coupled with a massive reduction
in the levels of Streptococcus. Types 5 and 6 were domi-
nated by well-known pathogens like H. influenzae and K.
pneumonia, but Type 4 was dominated by a previously
unknown one, Moraxella nonliquefaciens.
Effect of causal virus type and other variables on
microbiota
We elucidated the differences in bacterial profiles in the
context of causal agents of infections and demonstrated
that virus type did not determine the structural differ-
ences in bacterial communities (Additional file 4: Figure
S3A). Moreover, sex, sample type (swab, aspirate, or spu-
tum), and smoking status did not influence the bacterial
community structure (Additional file 4: Figures S3B, S3C
and S3D), which was also unaffected by the year and
month of sample collection (data not shown). By contrast,
subjects’ age was associated with the bacterial profile in a
statistically significant manner (Additional file 4: Figure
S3E), and the samples were categorized into 2 age groups,
0–5 and 6–90 years (p <0.0001, Hotelling’s test).
Moraxella nonliquefaciens and M. catarrhalis
In this study, we discovered a bacterial species that was
dominant in young patients (0–5 years old): M. nonli-
quefaciens was detected in 32.2% of the patients, with
abundance ratios of 0.03%–97.0% depending on the sub-
ject, but this species was not observed in any healthy
subject. Most of the patients (16 out of 19 cases) harboring
M. nonliquefaciens were under 6 years old. Two RSV in-
fected patients (RS1 and RS7) showed 95 and 97% of
abundance of M. nonliquefaciens, indicating that the upper
respiratory tracts of these patients were overwhelmed by
this bacterial species. In addition, a closely related patho-
genic species, M. catarrhalis, was detected in 23.7% of the
patients, with abundance ratios of 0.03%–26.5%.
Analyzing the 16S rRNA gene sequence revealed that
M. nonliquefaciens and M. catarrhalis were clearly dis-
tinct species that showed 98.4% similarity between type
strains (Additional file 5: Figure S4). The Moraxella con-
tigs recovered from patient samples were divided into 2
clades based on phylogenetic analysis (Figure 4). Clade I
was closely related (98.5%–99.8% 16S rRNA gene simi-
larity) to the type strain of M. nonliquefaciens. The
branching pattern of the contigs within the radiation of
Clade I indicated that M. nonliquefaciens populations in
the patients encompassed 3 phylogenetic lineages. Con-
tigs belonging to Clade II were clustered together with
M. catarrhalis (99.6%–100% 16S rRNA gene similarity),
and these contigs were further divided into 2 subpopula-
tions, Type 1 and Type 2 populations [29].
Evaluating potential pathogenicity of M. nonliquefaciens
based on genome sequences
To determine whether M. nonliquefaciens has a possibility
to be an opportunistic pathogen, its potential pathogen-
icity was inferred using the genome sequence of the type
strain. Genome sequencing identified a 2.22-Mb-sized
genome of M. nonliquefaciens DSM 6327T, featuring a
42.06% G + C ratio. The genomic relatedness calculated
using ANI showed that M. nonliquefaciens DSM 6327T
and M. catarrhalis RH4 shared low genomic relatedness,
75% ANI, which is considerably less than the cut-off value
used for species circumscription, 95%–96% ANI [30].
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Figure 1 Bacterial diversity observed in healthy-adult and patient
groups represented by Shannon index and number of phylotypes
(97% clustering). Healthy people contained more diverse bacterial
communities in their upper respiratory tract than did patients.
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Various proteins have been reported to play pivotal
roles in M. catarrhalis pathogenesis [31]. Thus, we
examined whether the virulence proteins in the M. cat-
arrhalis RH4 genome were also encoded in the newly
determined M. nonliquefaciens genome. The genes re-
sponsible for host-cell adhesion and invasion, evasion of
host immune system, and biofilm formation were in-
cluded as putative virulence factors. Comparative gen-
omic analysis revealed that most of the virulence genes
identified in M. catarrhalis were encoded in the M. non-
liquefaciens genome (Additional file 6: Table S2). More-
over, resistance to β-lactam antibiotics was predicted
based on the presence of the β-lactamase Class C gene.
However, BRO-1 and BRO-2 β-lactamases encoded by
most of M. catarrhalis strains were not detected in M.
nonliquefaciens.
Discussion
Our results demonstrated that changes in bacterial pro-
files elicited by viral infection were not associated with
the causal viral species: the microbiome compositions in
samples obtained from various viral infections were not
differentiated based on the causal infectious agents. Re-
gardless of the causal agents involved, the respiratory
tract microbiota of patients differed substantially from
the microbiota of healthy subjects in the kinds and
diversities of prevalent bacteria. However, the heteroge-
nicity of the patient group of this study (age, sampling
type, and number of samples/virus type) hinders strong
conclusions for this point. Nevertheless, the current
results from this study provide the first insight into
microbiome alterations associated with viral infection in
the upper respiratory tract.
Figure 2 Distinct populations of multiple genera observed in healthy-adult and patient groups. The 7-most dominant genera observed in
the samples were selected and are depicted in the radiation diagram. The height of each peak represents the percent ratio of the corresponding
genus in a sample. Streptococcus and Gemella dominated in the healthy-adult group, whereas the genera Haemophilus and Moraxella dominated
in the patient group.
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Figure 3 Dependence of microbiome structure on several key genera. Principal coordinate analysis (PCoA) of the bacterial communities isolated
from 57 healthy-adult and 59 patient samples was performed using the weighted pairwise UniFrac distance matrix. The UniFrac distance represents the
distance between 2 samples in terms of the microbial community structure. Samples are color-coded according to the 7 clustering groups.
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Figure 4 Phylogenetic tree based on 16S rRNA gene sequences showing the relationship of the newly discovered Moraxella sequences
with publically available sequences of other Moraxella strains. Representatives of 3M. catarrhalis type strains were included together with
the type strains of Moraxella species. Red text and blue test indicate M. nonliquefaciens contigs and M. catarrhalis contigs recovered from patient
samples, respectively. The neighbor-joining tree was evaluated using 1,000 bootstrap pseudoreplicates. Only bootstrap values over 70% are shown
at branch nodes. The scale bar represents the genetic distance.
Yi et al. BMC Infectious Diseases 2014, 14:583 Page 7 of 10
http://www.biomedcentral.com/1471-2334/14/583
The diminished bacterial diversity observed in patients
agreed well with previous studies reporting that the di-
versity in commensal airway microbiota declined follow-
ing infection by specific pathogens [6,13]. For example,
in the nares of patients with S. aureus carriage, species
diversity was half of that found in healthy adults’ nares
[6]. These results indicate that the normal microflora is
depleted in respiratory tract cells impaired due to viral
infection and is replaced by a few opportunistic patho-
gens. Moreover, the dominance of Streptococcus in the
respiratory tracts of healthy subjects (Table 1) agreed
with previous culture-independent massive metagenomic
sequencing studies [3,7]. Streptococcus is also known to
be abundant in the oral cavity [32,33]. Thus, the oro-
pharynx of healthy people could be characterized by
high bacterial diversity and by an overwhelming abun-
dance of the genus Streptococcus.
By analyzing the bacterial community, we defined 6
oropharyngeal types of bacterial populations in the
upper respiratory tract. We use the word “oropharyngeal
type” here based on the “enterotype” concept, which was
introduced by Arumugam et al. and defined as the clus-
ters of human gut microbiome determined based on
bacterial composition [34]. The concept suggests that
people can be classified into several enterotypes according
to the abundance of key bacterial taxa in gut microbial
communities [35]. In this study, the samples included
were restricted to one ethnic group, and thus the sug-
gested 6 oropharyngeal types may be accepted only tem-
porarily. However, because no other efforts to cluster
respiratory tract microbiomes have been reported to date,
our results may serve as a favorable starting point for
future studies on this subject.
Our results revealed that Haemophilus and Moraxella
were patient-specific genera. Unlike H. influenzae, M.
nonliquefaciens has not been studied for its possible role
in pneumonia. Although M. nonliquefaciens has been
isolated from clinical cases including chronic bronchitis
[36], bronchial infection [37], pneumonitis [38], endoph-
thalmitis [39], septic arthritis [40], thyroiditis [41], discitis
[42], botryomycosis [43], and endocarditis [44], this bac-
terium is widely considered to be a part of the normal
flora in the human upper respiratory tract and to exhibit
low pathogenicity [45,46]. By contrast, a closely related
species, M. catarrhalis, is a well-studied respiratory tract
pathogen that frequently colonizes the nasopharynx and is
an exclusively human pathogen that displays an affinity
for the human upper respiratory tract [47,48]. Long con-
sidered to be a commensal bacterium of the upper respira-
tory tract, M. catarrhalis has now been established as an
etiological cause of otitis media and the exacerbations of
chronic obstructive pulmonary disease (COPD) [47,49].
Despite the distinctiveness of the 2 species at the taxo-
nomic level, M. nonliquefaciens and M. catarrhalis share
several common features. First, the age-related incidence
of M. nonliquefaciens infection determined here is con-
cordant with that of M. catarrhalis. Previously, M. cat-
arrhalis was reported to be mostly associated with upper
respiratory tract infections in children [50], and its car-
riage rate was shown to be high in children (up to 75%)
and extremely low in healthy adults (1%–3%) [49,51-54].
Moreover, the phenotype and gene incidences of M. cat-
arrhalis isolates of children and adults presenting with
respiratory disease differ substantially, possibly as a re-
sult of immune evasion in adults [48]. The age-related
incidence of M. nonliquefaciens and M. catarrhalis may
be indicative of the weak pathogenicity of Moraxella
species, which may be unable to evade the well-established
immune system of adults.
Second, most strains of M. catarrhalis are known to
produce β-lactamases and thus exhibit ampicillin resist-
ance [49]. This antibiotic resistance was also predicted
in M. nonliquefaciens based on the presence of the Class
C β-lactamase gene. However, although both species
possess Class C β-lactamase genes, the species differ with
respect to the possession of BRO β-lactamase; BRO is
unique because it shows no substantial similarity to any
β-lactamase genes identified so far [55]. The absence of
BRO-1 and BRO-2 in M. nonliquefaciens suggests that
M. catarrhalis acquired the BRO genes by means of lat-
eral gene transfer after the 2 species evolved into distinct
lineages.
Third, all but one virulence factors reported for M.
catarrhalis were found to be encoded by M. nonliquefa-
ciens (Additional file 6: Table S2), which indicates that
M. nonliquefaciens has a high potential to be pathogenic
even though it is currently considered to be a com-
mensal bacterium. Several reasons may account for why
the overabundance of M. nonliquefaciens has not been
reported. Growing this organism and distinguishing it
from M. catarrhalis are challenging, which may have re-
sulted in a poor recognition of M. nonliquefaciens as a
respiratory pathogen. Moreover, although M. catarrhalis
is focused on by clinicians, the isolation of M. catarrhalis
from clinical samples is complicated by the presence of
Neisseria strains because these organisms share morpho-
logical similarities [49]. Furthermore, M. nonliquefaciens
may have been considerably underestimated because of
being misidentified as M. catarrhalis or Neisseria spp.
[49]. Lastly, the current absence of clinical interest or
familiarity with M. nonliquefaciens may have resulted in
under-reporting or identification of this pathogen. Indeed,
M. catarrhalis was previously underreported since other
better recognized pathogens were also recognized and
growing in the same cultures [49]. To clarify the incidence
of this potential pathogen, future studies will need to
differentiate between the true rates of incidence of M. cat-
arrhalis and M. nonliquefaciens. The results of this study
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suggest that M. nonliquefaciens deserves considerable
attention as a potential opportunistic pathogen in the
respiratory tract.
Conclusions
The pyrosequencing of bacterial community identified 6
oropharyngeal microbiome types in the upper respiratory
tract, but the bacterial profile was not related to the type
of causal infected viruses. The microbiota of patients dif-
fered substantially from that of healthy subjects in the
kinds and diversities of prevalent bacteria. Comparative
analysis of healthy adults and patients identified a bacter-
ium specific to young patients, M. nonliquefaciens. The
results of whole-genome sequencing raised the possibility
ofM. nonliquefaciens being an opportunistic pathogen.
Additional files
Additional file 1: Table S1. List and clinical characteristics of samples
used in this study. ND, not determined.
Additional file 2: Figure S1. Ordination diagram showing the relatedness
of microbiomes in the upper respiratory tract of healthy people. Principal
coordinate analysis (PCoA) of bacterial communities isolated from 57 healthy
adults was performed using the weighted pairwise UniFrac distance matrix.
The UniFrac distance represents the distance between 2 samples in terms of
the microbial community structure.
Additional file 3: Figure S2. Dendrogram and circle map showing the
clustering of samples into 6 groups depending on bacterial population
dynamics. The unweighted pair group method with arithmetic mean
(UPGMA) dendrogram was generated from the Fast UniFrac distance matrix
to hierarchically visualize the manner in which samples are grouped. The
relative abundance of representative microbial genera is indicated as a circle
map; circle sizes represent the percentage ratio within a sample.
Additional file 4: Figure S3. Ordination diagram showing the
relatedness of microbiomes in the upper respiratory tract of people
afflicted with diverse viral infections. We performed principal coordinate
analysis (PCoA) on the bacterial communities isolated from 57 healthy-adult
and 59 patient samples by using the weighted pairwise UniFrac distance
matrix. The UniFrac distance represents the distance between 2 samples in
terms of the microbial community structure. The structure of the bacterial
community was not affected by (A) the type of virus or by (B) the sex, (C)
sample type, and (D) smoking status of the subjects. However, (E) age was
correlated with the microbiome structure.
Additional file 5: Figure S4. Diagram showing the relationships
among the 2 type strains and the 2 representative contigs obtained from
patient samples. The average nucleotide identity (ANI) value indicating
genome relatedness was calculated using the complete genome sequence
of M. catarrhalis RH4 strain (PRJNA 48809), which shows 100% 16S rRNA
gene sequence identity with the type strain of the species.
Additional file 6: Table S2. Comparison of major virulence genes present
in M. nonliquefaciens and M. catarrhalis. The list of virulent genes was obtained
from previous reports [31,56]. The gene locus in each genome is presented
together with gene size in amino acids (in parenthesis).
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